semaglutide우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42608559
Maximizing weight loss with cagrisema: a systematic review and GRADE-assessed meta-analysis of randomized controlled trials.
Maximizing weight loss with cagrisema: a systematic review and GRADE-assessed meta-analysis of randomized controlled trials.
- 저자
- Bilal Wazir Khan, Syed AsadUllah Agha, Ihsan Qamar, Muhammad Huzaifa Khattak, Amna Rehman, Tayyaba Ikram Qazi
- 저널
- Naunyn-Schmiedeberg's archives of pharmacology
- 공개일
- 2026 Aug 17
- 연구 유형
- 기타
- DOI
- 10.1007/s00210-026-05809-5
문헌 요약
To evaluate the efficacy and safety of CagriSema, a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a Glucagon-Like Peptide-1 (GLP-1) receptor agonist, compared with placebo, cagrilintide, or semaglutide monotherapy in overweight or obese individuals. A systematic review and meta-analysis was conducted in accordance…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.